{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:50:25Z","timestamp":1780534225643,"version":"3.54.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Glob. Women\u2019s Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Stroke is often associated with the elderly population, but recent epidemiological data indicate an increasing incidence among young adults. Among the risk factors, estrogenic hormone therapy (HT) has been linked to cerebrovascular events. This report presents the case of a transgender woman who suffered an ischemic stroke during the inappropriate use of HT, highlighting the importance of medical follow-up and risk assessment in gender-affirming therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Description<\/jats:title><jats:p>A 30-year-old transgender female patient had been using estrogenic HT purchased on the black market (cyproterone 2\u2005mg\u2009+\u2009ethinyl estradiol 0.035 mg\/day) since the age of 17, without medical supervision. She had a history of HIV infection under irregular treatment and previously treated syphilis. She developed sudden-onset right-sided hemiparesis and homonymous hemianopsia. The initial computed tomography scan revealed no abnormalities, but magnetic resonance imaging showed ischemia in the territory of the left posterior cerebral artery. Etiological investigation with echocardiography, carotid and vertebral Doppler ultrasound, electrocardiogram, Holter monitoring, and thrombophilia panel revealed no abnormalities. The final etiological diagnosis was classified according to the TOAST criteria as \u201cother causes,\u201d attributed to the inappropriate use of estrogenic therapy. She was discharged with antiplatelet therapy, a statin, and fluoxetine, along with the discontinuation of hormone therapy and referral to transgender and vascular neurology outpatient clinics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>HT is essential in gender affirmation; however, its use is associated with increased risks of thromboembolic and cerebrovascular events. The patient in this case did not present traditional risk factors for stroke, reinforcing the suspicion of estrogen's role in the event. Studies suggest that supervised hormone therapy carries a lower risk of complications compared to indiscriminate use. Nonetheless, there are still gaps in the literature regarding the correlation between HT and stroke in transgender individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case highlights the risks of inappropriate use of gender-affirming hormone therapy and the need for rigorous medical supervision. Given the growing access to this treatment, continuous monitoring is essential to minimize complications. Further research is needed to establish safer guidelines for the use of hormone therapy in the transgender population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgwh.2025.1588553","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T13:38:13Z","timestamp":1754660293000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Ischemic stroke in a young transgender woman due to unsupervised estrogen therapy"],"prefix":"10.3389","volume":"6","author":[{"given":"Lucas Blanco","family":"Insaurralde da Luz Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andressa Camilo","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anny Gabriela Mar\u00e7al de Carvalho","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza Ferri","family":"Cury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela de Carvalho","family":"Flor\u00eancio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Boutrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciely Hyun Su Barakat","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidi Mayara Firmino","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana Karen","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Grat\u00e3o","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Ant\u00f4nio","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Pereira","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"B1","article-title":"Stroke: etiology, classification, and epidemiology","volume-title":"UpToDate","author":"Caplan","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/jnnp-2013-306203","article-title":"Trends in the incidence of ischemic stroke in young adults between 1985 and 2011: the dijon stroke registry","volume":"85","author":"B\u00e9jot","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/STROKEAHA.122.040524","article-title":"Risk factors and causes of ischemic stroke in 1322 young adults","volume":"54","author":"Ekker","year":"2023","journal-title":"Stroke"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1212\/WNL.0b013e318270401d","article-title":"Age at stroke: temporal trends in stroke incidence in a large, biracial population","volume":"79","author":"Kissela","year":"2012","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/jama.2022.12759","article-title":"Association of younger vs older ages with changes in incidence of stroke and other vascular events, 2002\u20132018","volume":"328","author":"Li","year":"2022","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","author":"Wierckx","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e16885","DOI":"10.1371\/journal.pone.0016885","article-title":"Long-term follow-up of transsexual persons undergoing sex reassignment surgery: cohort study in Sweden","volume":"6","author":"Dhejne","year":"2011","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1017\/cjn.2021.54","article-title":"Stroke in male-to-female transgenders: a systematic review and meta-analysis","volume":"49","author":"Ignacio","year":"2021","journal-title":"Can J Neurol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"100650","DOI":"10.1016\/j.cophys.2023.100650","article-title":"Cardiovascular disease and feminizing gender-affirming hormone therapy: implications for the provision of safe and lifesaving care","volume":"33","author":"Pribish","year":"2023","journal-title":"Curr Opin Physiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(16)00684-X","article-title":"Global health burden and needs of transgender populations: a review","volume":"388","author":"Reisner","year":"2016","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1303871","DOI":"10.3389\/fnhum.2023.1303871","article-title":"A mini-review of the evidence for cerebrovascular changes following gender-affirming hormone replacement therapy and a call for increased focus on cerebrovascular transgender health","volume":"17","author":"Wright","year":"2023","journal-title":"Front Hum Neurosci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/hypertensionaha.119.13080","article-title":"Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults","volume":"74","author":"Connelly","year":"2019","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cnur.2019.07.005","article-title":"Considerations for the care of transgender individuals","volume":"54","author":"Abeln","year":"2019","journal-title":"Nurs Clin North Am"},{"key":"B15","doi-asserted-by":"publisher","first-page":"81411","DOI":"10.1038\/s41598-021-81411-4","article-title":"Proportion of people identified as transgender and non-binary gender in Brazil","volume":"11","author":"Spizzirri","year":"2021","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0228765","DOI":"10.1371\/journal.pone.0228765","article-title":"The health status of transgender and gender nonbinary adults in the United States","volume":"15","author":"Cicero","year":"2020","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/s0140-6736(16)00683-8","article-title":"Transgender people: health at the margins of society","volume":"388","author":"Winter","year":"2016","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"718200","DOI":"10.3389\/fendo.2021.718200","article-title":"Cardiovascular risk associated with gender affirming hormone therapy in transgender population","volume":"12","author":"Aranda","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.3390\/ijms21155306","article-title":"HIV-associated risk factors for ischemic stroke and future perspectives","volume":"21","author":"Ismael","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.atherosclerosis.2006.12.022","article-title":"Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis","volume":"196","author":"Lorenz","year":"2008","journal-title":"Atherosclerosis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.atherosclerosis.2008.10.012","article-title":"Human immunodeficiency virus per se exerts atherogenic effects","volume":"204","author":"Oliviero","year":"2009","journal-title":"Atherosclerosis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1086\/605578","article-title":"Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy","volume":"49","author":"Ross","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1161\/STROKEAHA.110.583856","article-title":"Association between human immunodeficiency virus infection and stiffness of the common carotid artery","volume":"41","author":"Seaberg","year":"2010","journal-title":"Stroke"},{"key":"B24","first-page":"56","volume-title":"Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Programa Nacional de DST e Aids. Crit\u00e9rios de Defini\u00e7\u00e3o de Casos de Aids em Adultos e Crian\u00e7as","year":"2003"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJMra1906228","article-title":"Neurosyphilis","volume":"381","author":"Ropper","year":"2019","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.4158\/1934-2403-23.12.1437","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"23","author":"Hembree","year":"2017","journal-title":"Endocr Pract"},{"key":"B28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1590\/0034-7167-2016-0056","article-title":"Influence of hormonal contraceptives and the occurrence of stroke: integrative review","volume":"70","author":"Lima","year":"2017","journal-title":"Rev Bras Enferm"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","article-title":"Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy","volume":"139","author":"Nota","year":"2019","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000475","article-title":"2024 guideline for the primary prevention of stroke","volume":"55","author":"Bushnell","year":"2024","journal-title":"Stroke"},{"key":"B31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jcte.2015.02.003","article-title":"Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals","volume":"2","author":"Weinand","year":"2015","journal-title":"J Clin Transl Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.yhbeh.2012.06.002","article-title":"Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke","volume":"63","author":"Sohrabji","year":"2013","journal-title":"Horm Behav"}],"container-title":["Frontiers in Global Women's Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2025.1588553\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T13:38:18Z","timestamp":1754660298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2025.1588553\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":33,"alternative-id":["10.3389\/fgwh.2025.1588553"],"URL":"https:\/\/doi.org\/10.3389\/fgwh.2025.1588553","relation":{},"ISSN":["2673-5059"],"issn-type":[{"value":"2673-5059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"article-number":"1588553"}}